Evaluation of varenicline plus behavioural intervention in a group of Mexican smokers Source: Annual Congress 2008 - Smoking cessation and new tobacco uses Year: 2008
Efficacy of bupropion SR in a smoking cessation programme for heavy smokers: preliminary results Source: Eur Respir J 2001; 18: Suppl. 33, 167s Year: 2001
Efficacy of a smoking cessation program in anxious and depressed current smokers Source: Eur Respir J 2002; 20: Suppl. 38, 133s Year: 2002
Efficacy of bupropion in smokeless tobacco- A placebo control trial Source: Eur Respir J 2003; 22: Suppl. 45, 126s Year: 2003
Comparative effectiveness of add-on omalizumab for the treatment of severe persistent asthma between current and former smokers vs. non-smokers Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010
Efficacy of bupropion therapy in smoking cessation Source: Eur Respir J 2004; 24: Suppl. 48, 153s Year: 2004
Efficacy and safety of varenicline in a smokers population with high prevalence of comorbidities Source: Annual Congress 2010 - Smoking related diseases, damages due to environmental tobacco smoke and smoking control strategies Year: 2010
Efficacy and safety of bupropion for the treatment of smoking cessation in patients with chronic bronchitis Source: Eur Respir J 2004; 24: Suppl. 48, 503s Year: 2004
Comparison of effectiveness of varenicline and NRTs in smoking cessation in patients with chronic diseases Source: Annual Congress 2008 - Smoking cessation and new tobacco uses Year: 2008
Evaluation of prolonged bupropion treatment as an aid in smoking cessation Source: Eur Respir J 2002; 20: Suppl. 38, 611s Year: 2002
A pharmacological with nicotine or bupropion versus an integrated pharmacological and psychological program for smoking cessation Source: Eur Respir J 2002; 20: Suppl. 38, 579s Year: 2002
The cost-effectiveness of antidepressants for smoking cessation in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 801s Year: 2006
Comparison of efficacy of two smoking cessation methods among doctors-active smokers Source: Annual Congress 2010 - Smoking related diseases, damages due to environmental tobacco smoke and smoking control strategies Year: 2010
Intervention study to evaluate effectiveness of integrated therapy (varenicline plus montivational interviewing) for smoking cessation in diabetic patients: Source: Annual Congress 2012 - Smoking tobacco: from second hand to earthquake Year: 2012
Comparison of efficacy of varenicline and nortriptyline– Short-term smoking cessation in outpatient setting Source: International Congress 2016 – Emerging issues in smoking cessation and tobacco products Year: 2016
Smoking cessation and follow-up of depression in a group of Mexican smokers Source: Annual Congress 2008 - Towards smoking cessation Year: 2008
Effectiveness of varenicline treatment in a smoking cessation clinic Source: Annual Congress 2009 - Epidemiology of smoking and smoking cessation Year: 2009
Effectiveness of treatment with bupropion HCL, NRTs and combination in smoking cessation Source: Eur Respir J 2004; 24: Suppl. 48, 156s Year: 2004
Smoking cessation in COPD, modelling the cost effectiveness of minimal counseling or intensive counseling plus bupropion Source: Eur Respir J 2004; 24: Suppl. 48, 463s Year: 2004
Bupropion hydrochloride sustained release (SR) is an effective and well tolerated aid to smoking cessation in smokers with cardiovascular disease - a multicountry study Source: Eur Respir J 2001; 18: Suppl. 33, 12s Year: 2001